Fig. 3From: Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors3D pharmacophore models’ performance represented by their F1 score F1 and Mathew’s correlation coefficient MCC valuesBack to article page